AstraZeneca 2022: Alexion, cancer, COVID Issue Archives, October 2022, Therapeutics Alexion has boosted AstraZeneca’s rare disease expertise while the company has experienced success in oncology and COVID-19. Read more October 11, 2022/by Christiane Truelove https://www.pharmalive.com/wp-content/uploads/2020/10/tagrisso.jpg 1455 2250 Christiane Truelove https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Christiane Truelove2022-10-11 05:00:442022-10-19 11:10:02AstraZeneca 2022: Alexion, cancer, COVID
